About the ANCA-Associated Vasculitis Working Group
The methods for creating a composite outcome are different than for individual domain-directed outcomes and this Workshop will help attendees understand the steps required for this process through a project that is funded by ACR and EULAR to create response criteria for ANCA-associated vasculitis for use in clinical trials. Attendees are encouraged before the Workshop to view the short but highly informative videos developed to inform everyone on the disease under study and the methods employed for this project.

Haner Direskeneli
Co-Chair

Sarah Mackie
Co-Chair

Peter Merkel
Co-Chair

Gunnar Tómasson
Co-Chair

Kaitlin Quinn
Fellow

Sara Monti
Fellow

Georgia Lanier
Patient Research Partner
Vasculitis Overview
OMERACT Endorsed Core Domain Set for Clinical Trials in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

RECENT WORKING GROUP PUBLICATIONS
-
An international Delphi exercise to identify items of importance for measuring response to treatment in ANCA-associated vasculitis
-
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020
-
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody–associated Vasculitis